Clinical Trial Update: A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports long-term Spesolimab treatment in people with hidradenitis suppurativa who completed a prior trial; results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• SPESOLIMAB (BI655130)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2025-06-08